BAP1 and melanoma: Indeed, mutations in the deubiquitinating enzyme BRCA1-associated protein 1 (BAP1), in the E3 ligase (or E3 ligase complex) Parkinson protein 2 (PARK2), and in the F-box and WD repeat-containing 7 protein (FBXW7), were shown to favor melanoma development [3].